You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Claims for Patent: 11,623,010

✉ Email this page to a colleague

Summary for Patent: 11,623,010

Title:	Pharmaceutical carrier in the preparation of an anti-diabetic pharmaceutical composition and methods for treatment
Abstract:	The present invention relates to the use of a pharmaceutical carrier in the preparation of anti-diabetic pharmaceutical composition. In particular, the present invention relates to the use of a pharmaceutical carrier in the preparation of anti-diabetic pharmaceutical composition, wherein the pharmaceutical carrier consists of well-mixed sesame oil and beeswax, the anti-diabetic pharmaceutical composition comprises oryzanol and berberine hydrochloride as active ingredients; wherein the oryzanol is present in an amount of 1-5% by weight, the berberine hydrochloride is present in an amount of 5-50% by weight, the beeswax is present in an amount of 1-20% by weight, and the sesame oil is present in an amount of 40-85% by weight, relative to the total weight of the pharmaceutical composition. The present invention further relates to an anti-diabetic pharmaceutical composition as above, which is subjected to compressing, rinsing, drying and screening, and packaged into vial to obtain a product in soft capsule dosage form. The product has advantages such as stable control of blood glucose, lowering the level of blood glucose and blood lipid, protecting liver function, as well as low irritation on gastrointestinal tract.
Inventor(s):	Li Li
Assignee:	Beijing Rongxiang Institute Of Regenerative Medicine Co Inc , BEIJING RONGXIANG INSTITUTE OF REGENERATIVE MEDICINE Co Ltd
Application Number:	US16/553,056

Details for Patent 11,623,010

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	RYZODEG 70/30	insulin degludec and insulin aspart	Injection	203313	September 25, 2015	⤷ Get Started Free	2039-08-27
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,623,010

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
United States of America	2020069806	⤷ Get Started Free
San Marino	T202300198	⤷ Get Started Free
Serbia	64349	⤷ Get Started Free
Poland	3616697	⤷ Get Started Free
Hungary	E062396	⤷ Get Started Free
Croatia	P20230635	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.